Document:

Separation Agreement

 Exhibit 10.17 
 October 16, 2009 
 VIA PERSONAL DELIVERY 

 Rae Ann Werner 
  

	Re:	Separation Agreement 

 Dear Rae Ann:

 This letter sets forth the terms and conditions of our agreement (the “Agreement”) regarding the
resignation of your employment with Cymer, Inc. (the “Company”) and the related transition. This Agreement shall become effective on the “Effective Date” as defined in Section 10. You and the
Company hereby agree as follows: 
 1. Separation Date. You have tendered, and the Company has accepted, your resignation
effective January 8, 2010, or on such earlier date as the Company determines that you have failed to adequately fulfill your obligations pursuant to Section 2 of this Agreement (the “Separation Date”). 

2. Transition Services and Salary. During the time period from the date of this letter through December 18, 2009 (the
“Transition Period”), you will i) perform all services necessary to fully and effectively complete all corporate and accounting responsibilities in a professional manner; ii) communicate with all internal and external
contacts in a positive, professional and business appropriate manner according to the situation; iii) refrain from making any negative or disparaging remarks about the Company, its management, its board of directors, or its employees; iv) refrain
from soliciting, encouraging, or in any way suggesting or influencing members of the accounting team to leave, or consider leaving, their employment with the Company; v) ensure that all necessary information has been transitioned to the appropriate
employee(s). Although you will not be required to perform services for the Company after the Transition Period has concluded, provided that this Agreement becomes effective and provided that you comply with all material terms of this Agreement, you
will continue to receive your base salary in effect as of October 1, 2009 (less standard deductions and withholdings in accordance with the Company’s regular payroll practices) and you will continue to participate in those
Company-sponsored benefit programs in which you were enrolled as of October 1, 2009 through the Separation Date. 
 3. Stock
Options. All options previously granted to you to purchase the common stock of the Company (collectively, the “Options”) shall cease to vest effective on the Separation Date. Your right to exercise the Options as to any
vested shares will be governed by the relevant plan documents and stock option agreements. Attached hereto as Exhibit A is your Option Statement, specifying the number of vested shares you will hold as of January 8, 2010 provided that such date
is the Separation Date.

 
Rae Ann Werner 
 October 15, 2009 
 Page 2 
 4. Bonuses. Provided that
the Separation Date is January 8, 2010, you will receive the following bonus payments: i) the final payment under the 2006 LTIP Plan ($58,039.88, less required deductions), payable on the first payroll date of 2010; ii) the second payment under
the 2007 LTIP Plan ($15,300.30 cash, less required deductions and RSUs due under the plan on January 1, 2010), payable on the first payroll date of 2010; and iii) 2H-2009 bonus plan payment, or an equivalent amount, less required deductions,
payable when payments to other employees of the Company pursuant to the 2H-2009 bonus plan are issued. 
 5. Expense
Reimbursement. You will submit your final documented expense reimbursement statement reflecting all business expenses you incurred prior to and including the Separation Date, if any, for which you seek reimbursement no later than
February 1, 2010. The Company shall reimburse your expenses pursuant to Company policy and regular business practice. 
 6. Other
Compensation and Benefits. Except as expressly provided herein, you acknowledge and agree that you are not entitled to and will not receive any additional compensation, severance, or benefits from the Company. 
 7. Company Property. Upon the Separation Date, or such earlier date as the Company may specify, you will return to the Company all Company
documents (and all copies thereof) and other Company property in your possession or your control, including, but not limited to, Company files, business plans, notes, samples, drawings, specifications, calculations, sequences, data,
computer-recorded information, tangible property, including, but not limited to, cellular phones, computers, credit cards, entry cards, keys and any other materials of any nature pertaining to your work with the Company, and any documents or data of
any description (or any reproduction of any documents or data). 
 8. Confidentiality and Publicity. The provisions of this
Agreement shall be held in strictest confidence by you and shall not be publicized or disclosed in any manner whatsoever; provided, however, that you may disclose this Agreement, in confidence, (a) to your immediate family, (b) to
your attorneys, accountants, auditors, tax preparers, and financial advisors, and (c) insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law. 
 9. Release of Claims. In exchange for the consideration provided to you by this Agreement that you are not otherwise entitled to receive, you
hereby generally and completely release the Company and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns from any and all
claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring prior to your signing this Agreement. This general release includes, but is not limited to:
(1) all claims arising out of or in any way related to your employment with the Company or the termination of that employment; (2) all claims related to your compensation or benefits from the Company, including salary, bonuses, stock,
equity, commissions, vacation pay, expense reimbursements, severance pay, or fringe benefits; (3) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (4) all tort
claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (5) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, 

 Rae Ann Werner 
 October 15, 2009 
 Page 3 
 attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Employee Retirement Income Security
Act, the federal Age Discrimination in Employment Act of 1967 (as amended) (“ADEA”), California Labor Code §970, and the California Fair Employment and Housing Act (as amended). 
 10. ADEA. You acknowledge that you are knowingly and voluntarily waiving and releasing any rights you may have under the federal Age
Discrimination in Employment Act of 1967, as amended (“ADEA”). You also acknowledge that the consideration given for the waiver in the above paragraph is in addition to anything of value to which you were already entitled. You are advised
by this writing, as required by the ADEA that: (a) your waiver and release do not apply to any claims that may arise after you sign this Agreement; (b) You should consult with an attorney prior to executing this release; (c) you have
twenty-one (21) days within which to consider this release (although you may choose to voluntarily execute this release earlier); (d) you have seven (7) days following the execution of this release to revoke this Agreement; and
(e) this Agreement will not be effective until the eighth day after this Agreement has been signed both by you and by the Company, provided that you have not earlier revoked this Agreement (the “Effective Date”) and you
will not be entitled to receive any of the benefits specified by this Agreement unless it becomes effective. 
 11. Section 1542
Waiver. In giving this release, which includes claims which may be unknown to you at present, you hereby acknowledge that you have read and understand Section 1542 of the Civil Code of the State of California which reads as follows:

 A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time
of executing the release, which if known by him must have materially affected his settlement with the debtor. 
 You hereby expressly waive
and relinquish all rights and benefits under this section and any law or legal principle of similar effect in any jurisdiction with respect to claims released hereby. 
 12. Confidential Information and Proprietary Information Obligations. You hereby acknowledge that you have had access to confidential and proprietary information and trade secrets of the Company in
connection with your relationship therewith. You hereby acknowledge that such information includes, but is not limited to: (a) inventions, developments, designs, applications, improvements, trade secrets, formulae, methods or processes,
discoveries, techniques, plans, strategies and data (hereinafter “Inventions”); and (b) plans for research, development, new products, marketing and selling, information regarding business plans, budgets and unpublished
financial statements, licenses, prices and costs, information concerning potential and existing suppliers and customers and information regarding the skills and compensation of employees of the Company; and (c) information and advice relating
to the Company’s legal strategies and positions (collectively, with Inventions, hereinafter referred to as “Proprietary Information”). In view of the foregoing, you hereby agree, warrant and acknowledge that: 

(a) You will surrender and deliver to the Company no later than December 18, 2010 or such earlier date as specified by the
Company all documents, notes, laboratory notebooks, 

 Rae Ann Werner 
 October 15, 2009 
 Page 4 
 drawings, specifications, calculations, sequences, data and other materials of any nature pertaining to your work with the Company, and any documents or data of any description (or any reproduction of any
documents or data) containing or pertaining to any of the foregoing Proprietary Information. 
 (b) You have held and
will continue to hold in confidence and trust all Proprietary Information and shall not use or disclose any Proprietary Information or anything related to such information without the prior written consent of the Company. This commitment is in
addition to your obligation to hold in confidence all information subject to the attorney-client privilege. 
 (c) You
have assigned to the Company your entire right, title and interest in and to any and all Inventions (and all proprietary rights with respect thereto) whether or not patentable or registrable under copyright or similar statutes, made, conceived of,
reduced to practice, or learned, by you, either alone or jointly with others, during the course of your relationship with the Company. 
 (d) You will assist the Company in every proper way to obtain, and from time to time enforce, United States and foreign proprietary rights relating to Inventions in any and all countries. To that end you will execute, verify and
deliver such documents and perform such other acts (including appearances as a witness) as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such proprietary rights and the
assignment thereof. In addition, you will execute, verify and deliver assignments of such proprietary rights to the Company or its designee. Your obligation to assist the Company with respect to proprietary rights relating to such Inventions in any
and all countries shall continue beyond the termination of your employment, but the Company shall compensate you at a reasonable rate after your termination for the time actually spent by you at the Company’s request on such assistance.

 (e) In the event the Company is unable for any reason, after reasonable effort, to secure your signature on any
document needed in connection with the actions specified in the preceding paragraph, you hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as your agents and attorneys in fact, which appointment is
coupled with an interest, to act for and in your behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of the preceding paragraph with the same legal force and effect as if executed
by you. You hereby waive and quitclaim to the Company any and all claims, of any nature whatsoever, which you now or may hereafter have for infringement of any proprietary rights assigned hereunder to the Company. 
 (f) You acknowledge your continuing obligation to comply with your Employee Non-Disclosure Agreement (“NDA”), a copy of
which is attached as Exhibit C and incorporated by this reference. You represent that you have not violated and will not violate the NDA prior to the Effective Date or thereafter. 
 Your breach of the foregoing agreements and acknowledgments will result in unique and special harm to the Company and therefore the Company
shall have the right to enforce this Agreement and any of its provisions by injunction, specific performance or other equitable relief without prejudice to any other rights and remedies that the Company may have for a breach of this Agreement.

 Rae Ann Werner 
 October 15, 2009 
 Page 5 
 13. Non-disparagement. You agree that you will not at any time disparage the Company or its officers, directors, employees, shareholders and agents, in any manner likely to be harmful to
them or their business, business reputation or personal reputation; provided that you shall respond accurately and fully to any questions, inquiry or request for information when required by legal process. 
 14. Non-solicitation of Company Employees. You agree that for a period of twelve (12) months immediately following the Separation Date,
you shall not either directly or indirectly solicit, induce, recruit, influence, or encourage any of the Company’s employees to leave or curtail their employment with the Company. 
 15. Cooperation and Assistance. You agree that you will not voluntarily provide assistance, information or advice, directly or indirectly (including through agents or attorneys), to any
person or entity in connection with any claim by or against the Company, nor shall you induce or encourage any person or entity to do so. You agree that the foregoing sentence shall not prohibit you from testifying truthfully under subpoena or
providing other assistance under compulsion of law. You agree to provide (voluntarily and without legal compulsion) reasonable cooperation and accurate and complete information to the Company in the event of litigation involving the Company or its
officers or directors. 
 16. No Admissions. The parties hereto hereby acknowledge that this is a compromise settlement of various
matters, and that the promised payments in consideration of this Agreement shall not be construed to be an admission of any liability or obligation by either party to the other party or to any other person whomsoever. 
 17. Entire Agreement. This Agreement constitutes the complete, final and exclusive embodiment of the entire Agreement between you and the
Company with regard to the subject matter hereof. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein. It may not be modified except in a writing signed by you and a duly
authorized officer of the Company. Each party has carefully read this Agreement, has been afforded the opportunity to be advised of its meaning and consequences by his or its respective attorneys, and signed the same of his or its free will.

 18. Successors and Assigns. This Agreement shall bind the heirs, personal representatives, successors, assigns, executors, and
administrators of each party, and inure to the benefit of each party, its agents, directors, officers, employees, servants, heirs, successors and assigns. 
 19. Applicable Law. This Agreement shall be deemed to have been entered into and shall be construed and enforced in accordance with the laws of the State of California as applied to
contracts made and to be performed entirely within California. 

 Rae Ann Werner 
 October 15, 2009 
 Page 6 
 20. Severability. If a court of competent jurisdiction determines that any term or provision of this Agreement is invalid or unenforceable, in whole or in part, then the remaining terms and
provisions hereof shall be unimpaired. Such court will have the authority to modify or replace the invalid or unenforceable term or provision with a valid and enforceable term or provision that most accurately represents the parties’ intention
with respect to the invalid or unenforceable term or provision. 
 21. Indemnity. You represent that you have not assigned or
otherwise alienated the claims released by this Agreement and that you will indemnify and save harmless the Company from any loss incurred directly or indirectly by reason of the falsity or inaccuracy of said representation. 
 22. Authorization. You warrant and represent that there are no liens or claims of lien or assignments in law or equity or otherwise of or
against any of the claims or causes of action released herein and, further, that you are fully entitled and duly authorized to give the releases herein. 
 23. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, all of which together shall constitute one and the same instrument. 

24. Section Headings. The section and paragraph headings contained in this Agreement are for reference purposes only and shall not affect
in any way the meaning or interpretation of this Agreement. 
 Please sign and date below and return this Agreement to me. 
 Sincerely, 
 CYMER,
INC. 
  

	
	
	/s/ Teddi Reilly
	

 Teddi Reilly 
 Vice President, Global Human Resources 
 HAVING READ AND REVIEWED THE FOREGOING, I HEREBY AGREE TO AND ACCEPT THE TERMS AND CONDITIONS
OF THIS AGREEMENT AS STATED ABOVE. 
  

									
					
	Dated:	 	10/19/09	 		 		 	/s/ Rae Ann Werner
		 		 		 		 	Rae Ann WernerMemorandum of Understanding

 Exhibit 10.28 
 MEMORANDUM OF UNDERSTANDING 
 This Memorandum of
Understanding (this “MOU”), dated 14 January 2010, by and among Cymer, Inc., a Nevada corporation (“Cymer”), Carl Zeiss Laser Optics Beteiligungsgesellschaft mbH, a limited liability company
organized under the laws of Germany (“Zeiss LOB”), Carl Zeiss Laser Optics GmbH, a limited liability company organized under the laws of Germany (“Zeiss LO”), Carl Zeiss SMT AG, a stock corporation
organized under the laws of Germany (“Zeiss SMT” and together with Zeiss LOB and Zeiss LO, “Zeiss”), and TCZ Pte. Ltd., a company incorporated in Singapore (“TCZ”), sets forth
certain agreements among the parties to this MOU regarding the sale of Zeiss’s interest in TCZ to Cymer and related matters and to the extent necessary to accomplish such agreements amends the Joint Venture Documents as defined in
that certain Amended and Restated Joint Venture Agreement, dated 12 September 2006, among TCZ GmbH, a limited liability company organized under the laws of Switzerland, Cymer, Zeiss SMT, Zeiss LOB and TCZ. 
 NOW, THEREFORE, in consideration of the mutual promises contained herein and other good
and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows. 
 1.
BINDING TERMS. The parties to this MOU hereby agree to perform the transactions set forth on the term sheet attached as Exhibit A hereto, which forms an integral part of this MOU. 
 2. AMENDMENT OF JOINT VENTURE DOCUMENTS. The parties
to this MOU hereby agree that the Joint Venture Documents are amended by this MOU as set forth on Exhibit A hereto but only to such extent, and otherwise the terms of the Joint Venture Documents continue unchanged and remain in full force and
effect. 
 3. EXECUTION OF MOU. This MOU may be executed in one or more counterparts, each of which
shall be considered an original, but all of which counterparts together shall constitute one and the same instrument. 
 4.
GOVERNING LAW. This MOU shall be governed by, and construed under, the laws of New York (without regard to conflicts of laws principles). 
 IN WITNESS WHEREOF, the undersigned have caused this Memorandum of Understanding to be executed by their duly authorized representatives, effective as of
the date first set forth above. 
  

 1 

			
	CYMER, INC.
		
	By:	 	/s/ Edward J. Brown, Jr.
	Name:	 	 Edward J. Brown, Jr.

	Title:	 	 President and Chief Operating Officer

  

			
	 CARL ZEISS LASER OPTICS
     BETEILIGUNGSGESELLSCHAFT MBH

		
	By:	 	/s/ Roberto Deger
	Name:	 	 Roberto Deger

	Title:	 	 Managing Director

  

			
	CARL ZEISS LASER OPTICS GMBH
		
	By:	 	/s/ Dr. Karl Lamprecht
	Name:	 	 Dr. Karl Lamprecht

	Title:	 	 Managing Director

  

			
		
	By:	 	/s/ Gerhard Furter
	Name:	 	 Gerhard Furter

	Title:	 	 Member of the Board

  

			
	CARL ZEISS SMT AG
		
	By:	 	/s/ Dr. Andreas Dorsel
	Name:	 	 Dr. Andreas Dorsel

	Title:	 	 Member of the Board

  

			
		
	By:	 	/s/ Joseph Forlum
	Name:	 	 Joseph Forlum

	Title:	 	 Senior Director Administration

  

			
	TCZ PTE. LTD.
		
	By:	 	/s/ David S. Knowles
	Name:	 	 David S. Knowles

	Title:	 	 President & CEO, TCZ

 EXHIBIT A 
 TERM SHEET 
 Basic Terms: 
  

	1.	Zeiss has contributed their percentage (40%) of up to 2,0 Mio. USD capital funding to TCZ through September 30, 2009. After September 30, 2009 Zeiss will
not be required to contribute any additional capital funding to TCZ. 

  

	2.	The Parties agree that the Joint Venture Documents –as amended by the MOU– shall apply as if Carl Zeiss LOB (triggering party) had given notice in accordance
with Section 11.02 of the JV Agreement and Cymer had chosen option (i) of Section 11.02. 

  

	3.	Zeiss’ interest in the TCZ joint venture (Shareholders Equity) will be calculated as 40% of the Net Book Value TCZ as of January 15, 2010.

  

	4.	Cash payment of Zeiss’ interest in the TCZ joint venture will be made in three equal installments no later than March 31, 2010, June 30, 2010 and
September 30, 2010 (end of Zeiss fiscal year 2009/10). In addition, Cymer has a Prepayment Option for the Cash payment and can pay the outstanding amount at any time before September 30, 2010. Zeiss agrees to transfer all shares of TCZ
joint venture to Cymer on January 15, 2010 or as soon as possible thereafter against the commitment of Cymer for cash payment of Zeiss’ interest in the TCZ joint venture. If the decision is made by Cymer to discontinue the TCZ business
before all three cash payments are made to Zeiss then the remaining cash payments will be cancelled. If Cymer sells TCZ to a third party before the last of the three cash payments has been made and the price for TCZ is higher than the Net Book Value
as of January 15, 2010, then Cymer will adjust each outstanding cash payment to Zeiss such that the price for TCZ is used to calculate Zeiss’ interest. 

  

	5.	TCZ will pay Zeiss for modules, including spare parts, at disclosed cost until September 30, 2010 and cost plus 25% mark-up until TCZ reaches operational
profitability. Once TCZ reaches profitability TCZ and Zeiss will agree on a cost plus more than 25% mark-up for Zeiss modules. Payment terms are 60 days. 

  

	6.	Zeiss will continue to provide R&D resources and Integration Service support to TCZ at disclosed cost until September, 2010 and cost plus 15% mark-up thereafter.
Payment terms are 30 days. In addition based on TCZ’s plans as of December 2009, Zeiss reserves R&D capacity which TCZ commits to pay for until September 30, 2010 (end of Zeiss fiscal year 2009/10). 

  

	7.	Zeiss will support the relocation of TCZ Engineering, Application & System Integration to the new site and will be authorized to charge TCZ for all TCZ
approved Zeiss restructuring related costs. 

	8.	Zeiss will retain one observer board seat until the final cash payment for Zeiss’ interest has been made. Thereafter TCZ will hold a quarterly management review
meeting to update Zeiss on supplier relevant topics.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}]]